{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:51:07Z","timestamp":1768560667143,"version":"3.49.0"},"reference-count":148,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Health Management and Economics Research Center","award":["1403-4-113-31047"],"award-info":[{"award-number":["1403-4-113-31047"]}]},{"name":"Health Management Research Institute","award":["1403-4-113-31047"],"award-info":[{"award-number":["1403-4-113-31047"]}]},{"name":"Iran University of Medical Sciences","award":["1403-4-113-31047"],"award-info":[{"award-number":["1403-4-113-31047"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Patients with acute leukemia (AL) are at heightened risk of cardiovascular complications due to both disease-related and treatment-related factors. These complications include heart failure, arrhythmias, myocardial infarction, and thromboembolic events which may significantly impact morbidity and mortality. Objective: To identify the risk factors contributing to cardiovascular complications in patients with acute leukemia. Methods: This systematic review was conducted according to the PRISMA reporting guideline. Multiple databases including PubMed, Scopus, IEEE Xplore, the Cochrane Library, Web of Science, ProQuest, and Google Scholar were searched for studies published between 2020 and 2024. Eligible studies included those analyzing cardiovascular risk factors in AL patients across various subtypes and treatment stages. A total of 75 studies were included following rigorous screening and critical appraisal using tools appropriate for different study designs. Results: The results showed that cardiovascular complications in AL patients are multifactorial including demographic factors (e.g., age, sex, BMI), comorbidities (e.g., hypertension, diabetes, dyslipidemia), treatment exposures (e.g., anthracyclines, tyrosine kinase inhibitors, hematopoietic stem cell transplantation, radiation), and genetic predispositions (e.g., somatic and germline variants). Cardiac biomarkers (e.g., troponins, BNP), imaging (strain echocardiography), and electrocardiogram (ECG) abnormalities were key factors in detecting early or subclinical damage. Complications occurred both during and years after treatment, especially in childhood and long-term survivors. Conclusions: Cardiovascular complications are prevalent, and serious consequences in AL patients necessitate a personalized, multidisciplinary approach to risk stratification and monitoring. Considering clinical, genetic, and biomarker data can improve early detection and preventive strategies, ultimately enhancing patient outcomes.<\/jats:p>","DOI":"10.3390\/cancers17172777","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T10:35:17Z","timestamp":1756204517000},"page":"2777","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Determining Risk Factors Associated with Cardiovascular Complications in Patients with Acute Leukemia: A Systematic Review"],"prefix":"10.3390","volume":"17","author":[{"given":"Arezoo","family":"Abasi","sequence":"first","affiliation":[{"name":"Student Research Committee, Iran University of Medical Sciences, Tehran 14496-14535, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haleh","family":"Ayatollahi","sequence":"additional","affiliation":[{"name":"Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran 19967-13883, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soroush","family":"Rad","sequence":"additional","affiliation":[{"name":"Hematology, Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran 14117-13135, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjan","family":"Hajahmadipoor Rafsanjani","sequence":"additional","affiliation":[{"name":"Cardiovascular Department, Rasoul Akram General Hospital Iran University of Medical Sciences, Tehran 14456-13131, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"ref_1","unstructured":"Chennamadhavuni, A., Lyengar, V., Mukkamalla, S.K.R., and Shimanovsky, A. (2024). Leukemia. StatPearls, StatPearls Publishing LLC."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Xiao, W., Ma, L., Shang, Y., Yang, F., Tan, Y., Chen, G., Wu, J., Liang, Y., Rouzi, T., and Wang, Q. (2022). Cardiac-Related Lesions in Newly Diagnosed Patients with Acute Leukemia: A Chinese Population-Based Real-World Study. Front. Med., 9.","DOI":"10.3389\/fmed.2022.844350"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Siaravas, K.C., Moula, A.I., Tzourtzos, I.S., Ballas, C.E., and Katsouras, C.S. (2025). Acute and Chronic Cardiovascular Adverse Events in Patients with Acute Myeloid Leukemia: A Systematic Review. Cancers, 17.","DOI":"10.3390\/cancers17030541"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Boluda, B., Solana-Altabella, A., Cano, I., Mart\u00ednez-Cuadr\u00f3n, D., Acu\u00f1a-Cruz, E., Torres-Mi\u00f1ana, L., Rodr\u00edguez-Veiga, R., Navarro-Vicente, I., Mart\u00ednez-Campuzano, D., and Garc\u00eda-Ruiz, R. (2023). Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia. Cancers, 15.","DOI":"10.3390\/cancers15082267"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"109042","DOI":"10.1016\/j.thromres.2024.109042","article-title":"Acute cardiovascular complications of disseminated intravascular coagulation in acute myeloid leukemia","volume":"239","author":"Araji","year":"2024","journal-title":"Thromb. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1111\/bjh.16859","article-title":"High prevalence and incidence of cardiovascular disease in chronic lymphocytic leukaemia: A nationwide population-based study","volume":"190","author":"Larsson","year":"2020","journal-title":"Br. J. Haematol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaccao.2021.11.008","article-title":"Cardiovascular Disease Among Patients with AML and CHIP-Related Mutations","volume":"4","author":"Schoffel","year":"2022","journal-title":"JACC CardioOncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.amjcard.2023.11.039","article-title":"Cardiovascular Risk in Patients with Hematological Malignancies: A Systematic Review and Meta-Analysis","volume":"212","author":"Yong","year":"2024","journal-title":"Am. J. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jacc.2009.03.095","article-title":"Anthracycline-induced cardiomyopathy: Clinical relevance and response to pharmacologic therapy","volume":"55","author":"Cardinale","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1161\/ATVBAHA.119.313353","article-title":"Tyrosine kinase inhibitors in leukemia and cardiovascular events: From mechanism to patient care","volume":"40","author":"Manouchehri","year":"2020","journal-title":"ATVB"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.clon.2004.09.016","article-title":"Cardiac complications of radiation therapy","volume":"17","author":"Gaya","year":"2005","journal-title":"Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Militaru, A.G., Lighezan, D.F., Cimpean, A.M., Amaricai, E., and Militaru, M. (2025). Predicting Cardiovascular Risk Factors for Acute Leukemia Patients by Assessing Subclinical Atherosclerosis and Left Ventricular Function Before Chemotherapy. Life, 15.","DOI":"10.3390\/life15050704"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/ejh.13737","article-title":"Association between cardiovascular risk factors and intracranial hemorrhage in patients with acute leukemia","volume":"108","author":"Cornelissen","year":"2022","journal-title":"Eur. J. Haematol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e018403","DOI":"10.1161\/JAHA.120.018403","article-title":"Cardiovascular toxicity related to cancer treatment: A pragmatic approach to the American and European cardio-oncology guidelines","volume":"9","author":"Alexandre","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1200\/OP.20.00924","article-title":"Monitoring for Chemotherapy-Related Cardiotoxicity in the Form of Left Ventricular Systolic Dysfunction: A Review of Current Recommendations","volume":"17","author":"Stone","year":"2021","journal-title":"JCO Oncol. Pract."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"BMJ Syst. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"494","DOI":"10.11124\/JBIES-22-00430","article-title":"The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials","volume":"21","author":"Barker","year":"2023","journal-title":"JBI Evid. Synth."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jclinepi.2015.06.005","article-title":"ROBIS: A new tool to assess risk of bias in systematic reviews was developed","volume":"69","author":"Whiting","year":"2016","journal-title":"J. Clin. Epidemiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA\u2014A scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge","year":"2019","journal-title":"Res. Integr. Peer Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1547-5069.2001.00253.x","article-title":"The point of triangulation","volume":"33","author":"Thurmond","year":"2001","journal-title":"J. Nurs. Scholarsh."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Sohani, Z.N., Meyre, D., de Souza, R.J., Joseph, P.G., Gandhi, M., Dennis, B.B., Norman, G., and Anand, S.S. (2015). Assessing the quality of published genetic association studies in meta-analyses: The quality of genetic studies (Q-Genie) tool. BMC Genet., 16.","DOI":"10.1186\/s12863-015-0211-2"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.11124\/JBIES-24-00103","article-title":"The revised JBI critical appraisal tool for the assessment of risk of bias for cohort studies","volume":"23","author":"Barker","year":"2025","journal-title":"JBI Evid. Synth."},{"key":"ref_25","first-page":"217","article-title":"Chapter 7: Systematic reviews of etiology and risk","volume":"Volume 5","author":"Moola","year":"2017","journal-title":"Joanna Briggs Institute Reviewer\u2019s Manual"},{"key":"ref_26","first-page":"2127","article-title":"Methodological quality of case series studies: An introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid. Synth."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"ref_28","unstructured":"National Heart, L., and Institute, B. (2014). Quality Assessment Tool for Before-After (Pre-Post) Studies with no Control Group, National Heart, Lung, and Blood Institute."},{"key":"ref_29","first-page":"90","article-title":"Differential cardiac impacts of hematological malignancies and solid tumors: A histopathological and biomarker study","volume":"10","author":"Udin","year":"2024","journal-title":"Cardiooncology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1158\/1078-0432.CCR-24-0028","article-title":"A Phase 1 First-in-Human Study of the MCL-1 Inhibitor AZD5991 in Patients with Relapsed\/Refractory Hematologic Malignancies","volume":"30","author":"Desai","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaccao.2024.10.004","article-title":"Serum Proteins Predict Treatment-Related Cardiomyopathy Among Survivors of Childhood Cancer","volume":"7","author":"Poudel","year":"2025","journal-title":"JACC CardioOncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/a-2284-5855","article-title":"Cardio-Oncology: A New Discipline in Medicine and Its Relevance to Hematology","volume":"44","author":"Spannbauer","year":"2024","journal-title":"Hamostaseologie"},{"key":"ref_33","first-page":"e55108","article-title":"Cardiac Autonomic and Endothelial Function in Acute Lymphoblastic Leukaemia Patients Immediately After Chemotherapy and at the Three-Month Follow-up","volume":"16","author":"Sameer","year":"2024","journal-title":"Cureus"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1182\/bloodadvances.2024013535","article-title":"Cardiac events after allo-HCT in patients with acute myeloid leukemia","volume":"8","author":"Salas","year":"2024","journal-title":"Blood Adv."},{"key":"ref_35","first-page":"59","article-title":"Late Adverse Effects after Treatment for Childhood Acute Leukemia","volume":"53","author":"Roganovic","year":"2024","journal-title":"Acta Med. Acad."},{"key":"ref_36","first-page":"9","article-title":"Left and right ventricular global longitudinal strain assessment together with biomarker evaluation may have a predictive and prognostic role in patients qualified for hematopoietic stem cell transplantation due to hematopoietic and lymphoid malignancies\u2014A pilot study description","volume":"10","author":"Szmit","year":"2024","journal-title":"Cardiooncology"},{"key":"ref_37","first-page":"75","article-title":"Cardiotoxicity of venetoclax in patients with acute myeloid leukemia: Comparison with anthracyclines","volume":"10","author":"Onoue","year":"2024","journal-title":"Cardio-Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Ma, L., Wang, Q., Li, X., Shang, Y., Zhang, N., Wu, J., Liang, Y., Chen, G., Tan, Y., and Liu, X. (2024). Development of a risk assessment model for cardiac injury in patients newly diagnosed with acute myeloid leukemia based on a multicenter, real-world analysis in China. BMC Cancer, 24.","DOI":"10.1186\/s12885-024-11847-0"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Liu, X., Ge, S., and Zhang, A. (2024). Pediatric Cardio-Oncology: Screening, Risk Stratification, and Prevention of Cardiotoxicity Associated with Anthracyclines. Children, 11.","DOI":"10.3390\/children11070884"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"K\u0119pski, J., Szmit, S., and Lech-Mara\u0144da, E. (2024). Time Relationship between the Occurrence of a Thromboembolic Event and the Diagnosis of Hematological Malignancies. Cancers, 16.","DOI":"10.20944\/preprints202408.1362.v1"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Hellman, J., and Chaireti, R. (2024). Incidence and Risk Factors for Arterial Thrombosis in Patients with Acute Leukemia and Lymphoid Malignancies: A Retrospective Single-Center Study. Cancers, 16.","DOI":"10.3390\/cancers16142511"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S1470-2045(24)00157-8","article-title":"The burden of cardiovascular disease and risk for subsequent major adverse cardiovascular events in survivors of childhood cancer: A prospective, longitudinal analysis from the St Jude Lifetime Cohort Study","volume":"25","author":"Hammoud","year":"2024","journal-title":"Lancet Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaccao.2023.12.008","article-title":"Modifiable Cardiometabolic Risk Factors in Survivors of Childhood Cancer: JACC: CardioOncology State-of-the-Art Review","volume":"6","author":"Hammoud","year":"2024","journal-title":"JACC CardioOncol."},{"key":"ref_44","first-page":"60","article-title":"Diastolic function assessment with left atrial strain in long-term survivors of childhood acute lymphoblastic leukemia","volume":"77","author":"Ojeda","year":"2024","journal-title":"Rev. Esp. Cardiol."},{"key":"ref_45","first-page":"e75720","article-title":"Acute Ventricular Dysfunction After Doxorubicin-Based Induction Therapy for Pediatric Acute Lymphoblastic Leukemia","volume":"16","author":"Kundavaram","year":"2024","journal-title":"Cureus"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Dogliotti, I., Levis, M., Martin, A., Bartoncini, S., Felicetti, F., Cavallin, C., Maffini, E., Cerrano, M., Bruno, B., and Ricardi, U. (2024). Maintain Efficacy and Spare Toxicity: Traditional and New Radiation-Based Conditioning Regimens in Hematopoietic Stem Cell Transplantation. Cancers, 16.","DOI":"10.3390\/cancers16050865"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.cardfail.2023.10.477","article-title":"Sex Differences in the Development of Anthracycline-Associated Heart Failure","volume":"30","author":"Diaz","year":"2024","journal-title":"J. Card. Fail."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Rique, A., Cautela, J., Thuny, F., Michel, G., Ovaert, C., and El Louali, F. (2024). Left Ventricular Longitudinal Strain Abnormalities in Childhood Exposure to Anthracycline Chemotherapy. Children, 11.","DOI":"10.3390\/children11030378"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Barachini, S., Buda, G., and Petrini, I. (2024). Cardiovascular Toxicity of Antineoplastic Treatments in Hematological Diseases: Focus on Molecular Mechanisms to Improve Therapeutic Management. J. Clin. Med., 13.","DOI":"10.3390\/jcm13061574"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1016\/j.jtct.2023.10.026","article-title":"Impact of Hematopoietic Cell Transplantation on Cardiovascular Risk Factors and Insulin Sensitivity","volume":"30","author":"Ketterl","year":"2024","journal-title":"Transpl. Cell Ther."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1200\/JCO.22.01527","article-title":"Genome-Wide Association Study Identifies ROBO2 as a Novel Susceptibility Gene for Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors","volume":"41","author":"Wang","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Zhou, X., Weng, Y., Jiang, T., Ou, W., Zhang, N., Dong, Q., and Tang, X. (2023). Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients. BMC Cancer, 23.","DOI":"10.1186\/s12885-023-11060-5"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Mitrovic, M., Pantic, N., Sabljic, N., Bukumiric, Z., Virijevic, M., Pravdic, Z., Cvetkovic, M., Rajic, J., Bodrozic, J., and Milosevic, V. (2023). Arterial Thrombosis in Patients with Acute Myeloid Leukemia: Incidence and Risk Factors. Cancers, 15.","DOI":"10.3390\/cancers15113060"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ajh.26816","article-title":"Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results","volume":"98","author":"Kantarjian","year":"2023","journal-title":"Am. J. Hematol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Heredia, G., Gonzalez-Manzanares, R., Ojeda, S., Molina, J.R., Fernandez-Aviles, C., Hidalgo, F., Lopez-Aguilera, J., Crespin, M., Mesa, D., and Anguita, M. (2023). Right Ventricular Function in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia: From the CTOXALL Study. Cancers, 15.","DOI":"10.3390\/cancers15215158"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s11912-023-01445-x","article-title":"Cardiac Arrhythmias in Oncological Patients-Epidemiology, Risk Factors, and Management within the Context of the New ESC 2022 Guidelines","volume":"25","author":"Gawlik","year":"2023","journal-title":"Curr. Oncol. Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s10840-022-01400-z","article-title":"Tyrosine kinase inhibitor-associated ventricular arrhythmias: A case series and review of literature","volume":"66","author":"Fazal","year":"2023","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"ref_58","first-page":"40","article-title":"Cardiac electrical abnormalities in childhood acute lymphoblastic leukemia survivors: A systematic review","volume":"9","author":"Bertrand","year":"2023","journal-title":"Cardiooncology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"11531","DOI":"10.1007\/s00432-023-04984-9","article-title":"Preventive health care in blood cancer survivors: Results from the ABC study","volume":"149","author":"Baum","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_60","first-page":"1","article-title":"Late cardiac events after allogeneic stem cell transplant: Incidence, risk factors, and impact on overall survival","volume":"9","author":"Auberle","year":"2023","journal-title":"Cardiooncology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"100020","DOI":"10.1016\/j.ejcped.2023.100020","article-title":"Incidence and surveillance of acute cardiovascular toxicities in paediatric acute lymphoblastic leukaemia: A retrospective population-based single-centre cohort study","volume":"2","author":"Alpman","year":"2023","journal-title":"EJC Paediatr. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/hemato4010007","article-title":"Cardiotoxicity of Tyrosine Kinase Inhibitors in Philadelphia-Positive Leukemia Patients","volume":"4","author":"Berisha","year":"2023","journal-title":"Hemato"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-021-01221-z","article-title":"Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee","volume":"15","author":"Januzzi","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1002\/ehf2.14034","article-title":"Histopathological and epigenetic changes in myocardium associated with cancer therapy-related cardiac dysfunction","volume":"9","author":"Terada","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Perpinia, A.S., Kadoglou, N., Vardaka, M., Gkortzolidis, G., Karavidas, A., Marinakis, T., Papachrysostomou, C., Makaronis, P., Vlachou, C., and Mantzourani, M. (2022). Pharmaceutical Prevention and Management of Cardiotoxicity in Hematological Malignancies. Pharmaceuticals, 15.","DOI":"10.3390\/ph15081007"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Muggeo, P., Scicchitano, P., Muggeo, V.M.R., Novielli, C., Giordano, P., Ciccone, M.M., Faienza, M.F., and Santoro, N. (2022). Assessment of Cardiovascular Function in Childhood Leukemia Survivors: The Role of the Right Heart. Children, 9.","DOI":"10.3390\/children9111731"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Luo, Z., Cheng, J., and Wang, Y. (2022). Cardiac Infiltration as the First Manifestation of Acute Lymphoblastic Leukemia: A Systematic Review. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.805981"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/1055-9965.EPI-21-0360","article-title":"Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children\u2019s Oncology Group","volume":"31","author":"Lipshultz","year":"2022","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Gonzalez-Manzanares, R., Castillo, J.C., Molina, J.R., Ruiz-Ortiz, M., Mesa, D., Ojeda, S., Anguita, M., and Pan, M. (2022). Automated Global Longitudinal Strain Assessment in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia. Cancers, 14.","DOI":"10.3390\/cancers14061513"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Chianca, M., Panichella, G., Fabiani, I., Giannoni, A., L\u2019Abbate, S., Aimo, A., Del Franco, A., Vergaro, G., Grigoratos, C., and Castiglione, V. (2022). Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.936654"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1182\/hematology.2022000342","article-title":"Mitigating, monitoring, and managing long-term chemotherapy- and radiation-induced cardiac toxicity","volume":"2022","author":"Bottinor","year":"2022","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/17474086.2022.2054801","article-title":"Practical tips for managing FLT3 mutated acute myeloid leukemia with midostaurin","volume":"15","author":"Vendranas","year":"2022","journal-title":"Expert Rev. Hematol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2217\/pgs-2021-0067","article-title":"Genetic factors in treatment-related cardiovascular complications in survivors of childhood acute lymphoblastic leukemia","volume":"22","author":"Petrykey","year":"2021","journal-title":"Pharmacogenomics"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1536\/ihj.20-434","article-title":"Serial Changes in Cardiac Strain and Contractility After Hematopoietic Stem Cell Transplantation in Patients with Hematologic Malignancies","volume":"62","author":"Oka","year":"2021","journal-title":"Int. Heart J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1158\/1055-9965.EPI-20-1183","article-title":"The Contribution of Stress and Distress to Cardiovascular Health in Adult Survivors of Childhood Cancer","volume":"30","author":"Lubas","year":"2021","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_76","first-page":"8828410","article-title":"Cardiotoxicity: A Major Setback in Childhood Leukemia Treatment","volume":"2021","author":"Blag","year":"2021","journal-title":"Dis. Markers"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e29496","DOI":"10.1002\/pbc.29496","article-title":"Omega 3 fatty acids can reduce early doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukemia","volume":"69","author":"Khedr","year":"2022","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1042\/CS20200309","article-title":"Interactions between cardiology and oncology drugs in precision cardio-oncology","volume":"135","author":"Kamaraju","year":"2021","journal-title":"Clin. Sci."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Hoeben, B.A.W., Wong, J.Y.C., Fog, L.S., Losert, C., Filippi, A.R., Bentzen, S.M., Balduzzi, A., and Specht, L. (2021). Total Body Irradiation in Haematopoietic Stem Cell Transplantation for Paediatric Acute Lymphoblastic Leukaemia: Review of the Literature and Future Directions. Front. Pediatr., 9.","DOI":"10.3389\/fped.2021.774348"},{"key":"ref_80","unstructured":"Gangaraju, R. (2021). Risk of Coronary Heart Disease in Blood or Marrow Transplant Survivors. [Master\u2019s Thesis, The University of Alabama at Birmingham]."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jaccao.2021.02.011","article-title":"Early Cardiac Toxicity Associated with Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation","volume":"3","author":"Mohty","year":"2021","journal-title":"JACC CardioOncol."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Diesch-Furlanetto, T., Gabriel, M., Zajac-Spychala, O., Cattoni, A., Hoeben, B.A.W., and Balduzzi, A. (2021). Late Effects After Haematopoietic Stem Cell Transplantation in ALL, Long-Term Follow-Up and Transition: A Step Into Adult Life. Front. Pediatr., 9.","DOI":"10.3389\/fped.2021.773895"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s11764-020-00949-w","article-title":"Feasibility of a behavioral intervention using mobile health applications to reduce cardiovascular risk factors in cancer survivors: A pilot randomized controlled trial","volume":"15","author":"Chow","year":"2021","journal-title":"J. Cancer Surviv."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12170-020-00661-5","article-title":"CAR T Cell and BiTE Therapy\u2014New Therapies, New Risks?","volume":"15","author":"Chen","year":"2020","journal-title":"Curr. Cardiovasc. Risk Rep."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Burns, E.A., Gentille, C., Trachtenberg, B., Pingali, S.R., and Anand, K. (2021). Cardiotoxicity Associated with Anti-CD19 Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Recognition, Risk Factors, and Management. Diseases, 9.","DOI":"10.3390\/diseases9010020"},{"key":"ref_86","first-page":"e2034542","article-title":"Early-onset Cardiotoxicity assessment related to anthracycline in children with leukemia","volume":"52","year":"2021","journal-title":"A Prospect. Study. Colomb. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/ije\/dyaa184","article-title":"Chronic medical conditions and late effects after acute myeloid leukaemia in adolescents and young adults: A population-based study","volume":"50","author":"Huynh","year":"2021","journal-title":"Int. J. Epidemiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000501927","article-title":"Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management","volume":"143","author":"Saussele","year":"2020","journal-title":"Acta Haematol."},{"key":"ref_89","first-page":"328","article-title":"Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 study","volume":"136","author":"Orvain","year":"2020","journal-title":"Blood"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"243","DOI":"10.17219\/acem\/115082","article-title":"CIMT does not identify early vascular changes in childhood acute lymphoblastic leukemia survivors","volume":"29","author":"Ociepa","year":"2020","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1182\/bloodadvances.2019000955","article-title":"Anthracycline-related cardiotoxicity in older patients with acute myeloid leukemia: A Young SIOG review paper","volume":"4","author":"Neuendorff","year":"2020","journal-title":"Blood Adv."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jaccao.2020.08.006","article-title":"Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance: JACC CardioOncology State-of-the-Art Review","volume":"2","author":"Leerink","year":"2020","journal-title":"JACC CardioOncol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11899-020-00567-4","article-title":"The Cardiovascular Complications of Chimeric Antigen Receptor T Cell Therapy","volume":"15","author":"Jamal","year":"2020","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41569-020-0348-1","article-title":"Adverse cardiac effects of cancer therapies: Cardiotoxicity and arrhythmia","volume":"17","author":"Herrmann","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Giudice, V., Vecchione, C., and Selleri, C. (2020). Cardiotoxicity of Novel Targeted Hematological Therapies. Life, 10.","DOI":"10.3390\/life10120344"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Gavriilaki, E., Sakellari, I., Anyfanti, P., Batsis, I., Vardi, A., Bousiou, Z., Lazaridis, A., Nikolaidou, B., Zarifis, I., and Masmanidou, M. (2020). Assessment of Endothelial Injury and Pro-Coagulant Activity Using Circulating Microvesicles in Survivors of Allogeneic Hematopoietic Cell Transplantation. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249768"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11899-020-00585-2","article-title":"Advances in Supportive Care for Acute Lymphoblastic Leukemia","volume":"15","author":"Cook","year":"2020","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaccao.2020.09.006","article-title":"Genetics of Anthracycline Cardiomyopathy in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review","volume":"2","author":"Bhatia","year":"2020","journal-title":"JACC CardioOncol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e13476","DOI":"10.1111\/ijcp.13476","article-title":"Management strategies and clinical outcomes of acute myocardial infarction in leukaemia patients: Nationwide insights from United States hospitalisations","volume":"74","author":"Mohamed","year":"2020","journal-title":"Int. J. Clin. Pract."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/eurjpc\/zwaa034","article-title":"Cardiovascular risk factors during cancer treatment. Prevalence and prognostic relevance: Insights from the CARDIOTOX registry","volume":"29","author":"Albaladejo","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","article-title":"Shared Risk Factors in Cardiovascular Disease and Cancer","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.canep.2015.10.020","article-title":"Sex disparity in childhood and young adult acute myeloid leukemia (AML) survival: Evidence from US population data","volume":"39","author":"Hossain","year":"2015","journal-title":"Cancer Epidemiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"6121","DOI":"10.1182\/blood-2024-211874","article-title":"Sex Differences in Disease Characteristics and Outcome in Adults with Acute Myeloid Leukemia from China","volume":"144","author":"Li","year":"2024","journal-title":"Blood"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e5300","DOI":"10.1097\/MD.0000000000005300","article-title":"A childhood acute lymphoblastic leukemia genome-wide association study identifies novel sex-specific risk variants","volume":"95","author":"Singh","year":"2016","journal-title":"Medicine"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaccao.2024.07.016","article-title":"Anthracycline Cardiotoxicity in Adult Cancer Patients: JACC: CardioOncology State-of-the-Art Review","volume":"6","author":"Camilli","year":"2024","journal-title":"JACC CardioOncol."},{"key":"ref_106","first-page":"250","article-title":"Cardio-Oncology: A Focused Review of Anthracycline-, Human Epidermal Growth Factor Receptor 2 Inhibitor-, and Radiation-Induced Cardiotoxicity and Management","volume":"16","author":"Domercant","year":"2016","journal-title":"Ochsner J."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10557-016-6711-0","article-title":"Anthracycline chemotherapy and cardiotoxicity","volume":"31","author":"McGowan","year":"2017","journal-title":"Cardiovasc. Drug Ther. J."},{"key":"ref_108","first-page":"111","article-title":"Cardiotoxicity of Anthracyclines","volume":"43","author":"Balough","year":"2025","journal-title":"Cardiol. Clin."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e1113","DOI":"10.1161\/CIR.0000000000001220","article-title":"Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement from the American Heart Association","volume":"149","author":"Hayek","year":"2024","journal-title":"Circulation"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e1113","DOI":"10.3390\/jpm11080715","article-title":"Targeted Therapy in Acute Lymphoblastic Leukaemia","volume":"11","author":"Salvaris","year":"2021","journal-title":"J. Pers. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijcard.2020.05.077","article-title":"Cardiotoxicity of the BCR-ABL1 tyrosine kinase inhibitors: Emphasis on ponatinib","volume":"316","author":"Singh","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41392-023-01469-6","article-title":"Adverse effects of tyrosine kinase inhibitors in cancer therapy: Pathophysiology, mechanisms and clinical management","volume":"8","author":"Sharma","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11936-019-0737-0","article-title":"Cardiovascular Complications Associated with Mediastinal Radiation","volume":"21","author":"Nahhas","year":"2019","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Nishikawa, T., Miyahara, E., Kurauchi, K., Watanabe, E., Ikawa, K., Asaba, K., Tanabe, T., Okamoto, Y., and Kawano, Y. (2015). Mechanisms of fatal cardiotoxicity following high-dose cyclophosphamide therapy and a method for its prevention. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0131394"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Zhao, Y., He, R., Oerther, S., Zhou, W., Vosough, M., and Hassan, M. (2022). Cardiovascular Complications in Hematopoietic Stem Cell Transplanted Patients. J. Pers. Med., 12.","DOI":"10.3390\/jpm12111797"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1038\/s41409-021-01427-2","article-title":"Cardiac complications associated with hematopoietic stem-cell transplantation","volume":"56","author":"Ohmoto","year":"2021","journal-title":"Bone Marrow Transplant."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e846","DOI":"10.1097\/HS9.0000000000000846","article-title":"Prediction of Nonrelapse Mortality in Patients with Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation with Posttransplantation Cyclophosphamide-based Graft Versus Host Disease Prophylaxis","volume":"7","author":"Hermans","year":"2023","journal-title":"Hemasphere"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1182\/blood-2010-08-301713","article-title":"The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML","volume":"117","author":"Kayser","year":"2011","journal-title":"Blood"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Lica, J.J., Pradhan, B., Safi, K., Jak\u00f3bkiewicz-Banecka, J., and Hellmann, A. (2024). Promising Therapeutic Strategies for Hematologic Malignancies: Innovations and Potential. Molecules, 29.","DOI":"10.3390\/molecules29174280"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"107456","DOI":"10.1016\/j.leukres.2024.107456","article-title":"Clinical outcomes of patients with acute myeloid leukemia and cardiovascular disease","volume":"138","author":"Goloubeva","year":"2024","journal-title":"Leuk. Res."},{"key":"ref_121","first-page":"270","article-title":"Cardiovascular involvement in blood cancers: ALL, AML, CLL, and CML","volume":"11","author":"Yazdanparast","year":"2021","journal-title":"Iran. J. Pediatr. Hematol. Oncol."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Sulicka-Grodzicka, J., Chyrchel, B., Toto\u0144-\u017bura\u0144ska, J., Nowak, E., Wo\u0142kow, P.P., Surdacki, A., and Grodzicki, T. (2019). Cranial Irradiation in Childhood Acute Lymphoblastic Leukemia Is Related to Subclinical Left Ventricular Dysfunction and Reduced Large Artery Compliance in Cancer Survivors. J. Clin. Med., 8.","DOI":"10.3390\/jcm8111952"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1200\/JCO.18.00313","article-title":"Occurrence of Treatment-Related Cardiotoxicity and Its Impact on Outcomes Among Children Treated in the AAML0531 Clinical Trial: A Report from the Children\u2019s Oncology Group","volume":"37","author":"Getz","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/CIRCIMAGING.112.973321","article-title":"Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab","volume":"5","author":"Sawaya","year":"2012","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Zhang, X., Sun, Y., Zhang, Y., Fang, F., Liu, J., Xia, Y., and Liu, Y. (2022). Cardiac Biomarkers for the Detection and Management of Cancer Therapy-Related Cardiovascular Toxicity. J. Cardiovasc. Dev. Dis., 9.","DOI":"10.3390\/jcdd9110372"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"e029574","DOI":"10.1161\/JAHA.123.029574","article-title":"Circulating Cardiovascular Biomarkers in Cancer Therapeutics-Related Cardiotoxicity: Review of Critical Challenges, Solutions, and Future Directions","volume":"12","author":"Murtagh","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Semeraro, G.C., Cipolla, C.M., and Cardinale, D.M. (2021). Role of cardiac biomarkers in cancer patients. Cancers, 13.","DOI":"10.3390\/cancers13215426"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/ejhf.2017","article-title":"Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: A position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology","volume":"22","author":"Pudil","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Skitch, A., Mital, S., Mertens, L., Liu, P., Kantor, P., Grosse-Wortmann, L., Manlhiot, C., Greenberg, M., and Nathan, P.C. (2017). Novel approaches to the prediction, diagnosis and treatment of cardiac late effects in survivors of childhood cancer: A multi-centre observational study. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3505-0"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1182\/blood-2020-143026","article-title":"IDH Mutations Are Associated with an Increased Risk of Coronary Artery Disease and Cardiotoxicity in Patients with Established AML","volume":"136","author":"Kattih","year":"2020","journal-title":"Blood"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1182\/blood-2023-190177","article-title":"The Occurrence of Infection and TP53 Mutation Are Risk Factors for Cardiovascular Toxicity of Acute Myeloid Leukemia Induction Therapy","volume":"142","author":"Kemp","year":"2023","journal-title":"Blood"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.amjcard.2024.06.033","article-title":"Symptomatic Heart Failure and Clonal Hematopoiesis-Related Mutations in Patients with Acute Myeloid Leukemia","volume":"226","author":"Kang","year":"2024","journal-title":"Am. J. Cardiol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"e030603","DOI":"10.1161\/JAHA.123.030603","article-title":"Clonal hematopoiesis of indeterminate potential from a heart failure specialist\u2019s point of view","volume":"12","author":"Sikking","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1200\/JCO.2011.34.8987","article-title":"Anthracycline-related cardiomyopathy after childhood cancer: Role of polymorphisms in carbonyl reductase genes\u2013a report from the Children\u2019s Oncology Group","volume":"30","author":"Blanco","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1124\/dmd.107.014779","article-title":"A functional genetic polymorphism on human carbonyl reductase 1 (CBR1 V88I) impacts on catalytic activity and NADPH binding affinity","volume":"35","author":"Ghosh","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1161\/CIRCULATIONAHA.105.576850","article-title":"NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity","volume":"112","author":"Wojnowski","year":"2005","journal-title":"Circulation"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1634\/theoncologist.2012-0239","article-title":"Association of anthracycline-related cardiac histological lesions with NADPH oxidase functional polymorphisms","volume":"18","author":"Cascales","year":"2013","journal-title":"Oncologist"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/bjh.12516","article-title":"Genetic susceptibility to anthracycline-related congestive heart failure in survivors of haematopoietic cell transplantation","volume":"163","author":"Armenian","year":"2013","journal-title":"Br. J. Haematol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaccao.2024.06.006","article-title":"Cardiovascular Considerations After Cancer Therapy","volume":"7","author":"Blaes","year":"2025","journal-title":"JACC CardioOncol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41409-020-01021-y","article-title":"Cardiovascular outcomes in patients receiving myeloablative vs. reduced intensity conditioning prior to allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia","volume":"56","author":"Hefazi","year":"2021","journal-title":"Bone Marrow Transpl."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"263","DOI":"10.21037\/cdt-20-302","article-title":"Pathophysiology of heart failure","volume":"11","author":"Schwinger","year":"2021","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Izquierdo-Condoy, J.S., Arias-Intriago, M., Becerra Cardona, D.A., Garc\u00eda-Ca\u00f1arte, S., and Vinueza-Moreano, P. (2025). Anticancer Chemotherapy-Induced Atherosclerotic Cardiovascular Disease: A Comprehensive Review. Life, 15.","DOI":"10.3390\/life15020245"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Xiong, Z., Liao, Y., Zhang, Z., Wan, Z., Liang, S., and Guo, J. (2025). Molecular Insights into Oxidative-Stress-Mediated Cardiomyopathy and Potential Therapeutic Strategies. Biomolecules, 15.","DOI":"10.3390\/biom15050670"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1586\/ehm.11.8","article-title":"Adverse effects of treatment in childhood acute lymphoblastic leukemia: General overview and implications for long-term cardiac health","volume":"4","author":"Ness","year":"2011","journal-title":"Expert Rev. Hematol."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Konstantinidis, I., Tsokkou, S., Grigoriadis, S., Chrysavgi, L., and Gavriilaki, E. (2024). Cardiotoxicity in Acute Myeloid Leukemia in Adults: A Scoping Study. Cancers, 16.","DOI":"10.3390\/cancers16132474"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Lazar, D.R., Maniu, D., Lazar, F.-L., Blag, C., Bota, M., Zdrenghea, M., and Cainap, S. (2025). Exploring the baseline cardiac function and its correlation with risk stratification in children diagnosed with acute lymphoblastic leukemia. Ann. Hematol., 1\u20138.","DOI":"10.1007\/s00277-025-06523-7"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.blre.2018.01.004","article-title":"Cardiovascular, pulmonary, and metabolic toxicities complicating tyrosine kinase inhibitor therapy in chronic myeloid leukemia: Strategies for monitoring, detecting, and managing","volume":"32","author":"Medeiros","year":"2018","journal-title":"Blood Rev."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/17\/2777\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:32:57Z","timestamp":1760034777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/17\/2777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":148,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["cancers17172777"],"URL":"https:\/\/doi.org\/10.3390\/cancers17172777","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]}}}